Background Image
Table of Contents Table of Contents
Previous Page  6 / 74 Next Page
Basic version Information
Show Menu
Previous Page 6 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 5, September/October 2014

200

AFRICA

Cardiovascular Topics

Diagnostic value of plasma C-type natriuretic peptide

levels in determination of the duration of mesenteric

ischaemia

Sinan Demirtas, Oguz Karahan, Suleyman Yazici, Orkut Guclu, Ahmet Caliskan, Orhan Tezcan, Celal Yavuz

Abstract

Objective:

Mesenteric arteries release C-type natriuretic

peptide (CNP), which hyperpolarises vascular smooth muscle.

We measured the levels of this peptide after inducing mesen-

teric ischaemia over a series of time intervals, so as to deter-

mine its predictive value in demonstrating the severity of

ischaemia in a rat model.

Methods:

A total of 32 rats were allocated to four groups

containing eight rats each. Basal CNP reference levels were

measured in the control group, which was not exposed to any

intervention. In groups I, II and III, mesenteric ischaemia

was induced over three, six and nine hours, respectively, and

plasma CNP levels were measured afterwards. Mesenteric

ischaemia was induced by clamping the superior mesenteric

artery.

Results:

In comparison with the controls (2.38

±

0.18 pg/ml),

CNP levels were relatively lower in group I (2.54

±

0.42 pg/

ml). However, significant increases in plasma CNP levels were

observed over longer periods of ischaemia in group II, at 5.23

±

0.22 pg/ml, and in group III, at 6.19

±

0.67 pg/ml (

p

<

0.05).

A significant direct relationship was determined between

plasma CNP levels and prolonged intervals of mesenteric

ischaemia (

R

=

0.56,

p

<

0.001).

Conclusion:

Measuring plasma CNP levels in patients with

acute mesenteric ischaemia may be beneficial in estimating

the time period over which the ischaemic injury has occurred.

Keywords:

C-type natriuretic peptide, mesenteric ischaemia,

ischaemia duration

Submitted 3/4/14, accepted 4/6/14

Cardiovasc J Afr

2014;

25

: 200–203

www.cvja.co.za

DOI: 10.5830/CVJA-2014-033

Acute mesenteric ischaemia (AMI) causes significant morbidity

and mortality if not promptly diagnosed and treated. If medical

interventions are delayed, the patient may sustain serious

ischaemic injury leading to bowel necrosis, so large segments

of bowel may require surgical resection. Often these patients

have poor clinical outcomes and suffer from complications such

as malnutrition.

1,2

Mesenteric ischaemia makes up 0.1% of all

hospital admissions.

1

Even though technological advances have

been made in diagnostic laboratory and imaging techniques,

AMI remains fatal in 60% of patients diagnosed with this

condition.

1,3

Scientists have been investigating whether there are specific

sensitive biomarkers that may indicate the presence of AMI.

2,4

Several endothelial markers have been identified as putative

biomarkers that may reveal the severity and duration over which

mesenteric ischaemia has been sustained.

5

However, markers

that are effective enough for use in clinical practice have yet to

be identified.

Natriuretic peptides, namely atrial natriuretic peptide (ANP),

brain natriuretic peptide (BNP), and C-type natriuretic peptide

(CNP) function in maintaining fluid and electrolyte balance as

well as blood vessel tone. CNP is released by vascular endothelial

cells, and this biomarker’s function in influencing vascular tone

has been investigated.

6,7

It has been hypothesised that CNP is

an endothelium-derived hyperpolarising factor (EDHF) that

specifically affects the degree of resistance in the mesenteric

arteries.

8

In this study, we aimed to investigate plasma CNP levels

during early and advanced stages of mesenteric ischaemia so as

to determine whether CNP levels are a good indicator of severity

of AMI in a rat model.

Methods

The study protocol was created in accordance with the Animal

Welfare Act and the Guide for the Care and Use of Laboratory

Animals created by the university ethics committee. The rats

were obtained and housed in the laboratory of the University’s

animal production unit. They were maintained in a controlled

environment with 12-hour light–dark cycles, and the cages were

kept at a constant humidity of 50

±

5% and temperature of 22

±

2°C.

A total of 32 male Sprague-Dawley rats between the ages of

eight and 12 weeks and weighing 230

±

30 g (mean

±

standard

deviation) were randomly allocated to four different groups.

The induction of sedation was achieved with an intraperitoneal

Medical School of Dicle University, Department of

Cardiovascular Surgery, Diyarbakir, Turkey

Sinan Demirtas, MD,

sinandemirtas78@hotmail.com

Oguz Karahan, MD

Suleyman Yazici, MD

Orkut Guclu, MD

Ahmet Caliskan, MD

Orhan Tezcan, MD

Celal Yavuz, MD